CHICAGO, June 4 (Reuters) – A new wave of experimental
cancer drugs that directly recruit the immune system’s powerful
T cells could begin reaching patients next year, according to
companies…
The post Juno, Kite Pharma: cancer cell therapies could be approved next year appeared first on NASDAQ.